Deals this week: Ferring Pharmaceuticals, Mirati, Juvenescence

Ferring Pharmaceuticals (US) has entered an exclusive agreement with Sun Pharmaceutical Industries to acquire the commercialisation rights for a generic version of Ganirelix Acetate injection in the US.